PROVIDER PROFILE · NPI 1356495949

Michael GrunwaldMD

PRACTICETHE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITYSee all providers at this practice →

Hematology-OncologyCharlotte, NCI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

202

Distinct HCPCS

Medicare payment

$15K

Peer benchmark

Total Medicare services vs. 329 Hematology-Oncology providers in NC — bottom quintile (cohort median 605).

PRESCRIBING · PART D · 2024

Total Rx claims

556

Beneficiaries

—

Total drug cost

$3.6M

Distinct drugs

Brand share

50.7%

Top prescribed drugs

Ruxolitinib Phosphate122 claims

Acyclovir79 claims

Hydroxyurea34 claims

Venetoclax28 claims

Posaconazole28 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

13.6

Cost

75.5

Improvement activities

40.0

Promoting interop.

99.0

Payment adjustment

1.05%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$45K

Payment records

By payment type

Consulting Fee$36K

Travel and Lodging$4K

Food and Beverage$3K

Honoraria$2K

REFERRAL NETWORK

Where Michael Grunwald's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
CAROLINAS MEDICAL CENTER	55	1,019

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
CAROLINAS MEDICAL CENTER	42	737
Edward Lipford Pathology · Charlotte, NC	20	111
Jared Block Pathology · Charlotte, NC	15	56
LITTMANN, LASZLO	14	48
COGDILL, TAMMY	12	53

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history